Cargando…
Dedifferentiated endometrioid adenocarcinoma with trophoblastic components and elevated serum alfa-fetoprotein: A case report and literature review
RATIONALE: Dedifferentiated endometrioid adenocarcinoma (DEAC) consisted of a combination of undifferentiated and differentiated carcinoma is more aggressive than other conventional endometrioid adenocarcinomas. PATIENT CONCERNS: A 33-year-old woman with atypical vaginal bleeding was refereed to our...
Autores principales: | Cai, He, Zhou, Rong, Liang, Wanying, Wang, Jianliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944540/ https://www.ncbi.nlm.nih.gov/pubmed/29703038 http://dx.doi.org/10.1097/MD.0000000000010551 |
Ejemplares similares
-
Dedifferentiated endometrioid adenocarcinoma with trophoblastic components: Prolonged remission after treatment with bleomycin, etoposide, and cisplatin
por: Martin, Alexa K., et al.
Publicado: (2020) -
Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature
por: Goh, C., et al.
Publicado: (2020) -
Dedifferentiated endometrioid adenocarcinoma: An under-recognized but aggressive tumor?()
por: Wu, Emily S., et al.
Publicado: (2013) -
Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases
por: Yiğit, Seyran, et al.
Publicado: (2018) -
Dedifferentiated Endometrioid Adenocarcinoma of the Uterus: Highly Aggressive and Poor Prognostic Tumor
por: Park, Shin Young, et al.
Publicado: (2014)